Related Experiment Videos
Hypothesis: Jadassohn nevus phakomatosis: a paracrinopathy with variable phenotype.
1Division of Medical Genetics, University of South Florida, Tampa 33612-4799.
American Journal of Medical Genetics
|July 1, 1992
Summary
Jadassohn nevus phakomatosis (JNP) and neurofibromatosis type 1 (NF-1) may be paracrine growth regulation disorders. These conditions involve lifelong dysregulation of growth factors, leading to varied skin and systemic anomalies.
Area of Science:
- Dermatology
- Genetics
- Endocrinology
Background:
- Phakomatoses are hypothesized to be paracrine growth regulation disorders (paracrinopathies).
- Jadassohn nevus phakomatosis (JNP) exhibits significant phenotypic variability and dynamic changes over time.
- Neurofibromatosis type 1 (NF-1) also shows evidence of growth factor dysregulation.
Purpose of the Study:
- To investigate if Jadassohn nevus phakomatosis (JNP) fits the pathogenetic model of paracrinopathies.
- To analyze the phenotype of JNP patients and review existing literature.
- To explore the role of paracrine growth factors in JNP and compare it with NF-1.
Main Methods:
- Phenotype analysis of 13 JNP propositi and a review of reported JNP cases.
- Long-term observation of JNP patients to document phenotypic changes.
- Review of laboratory evidence from NF-1 patients, including tissue culture and radioimmunoassays.
Main Results:
- JNP phenotypes range from solitary nevi to extensive lesions with systemic anomalies.
- Observed changes in JNP include benign/malignant tumors, renal rickets, hepatomegaly, and vasculopathy.
- NF-1 skin showed increased melanin macroglobuli; neurofibromas had elevated somatomedin-C (IGF-I) levels.
Conclusions:
- JNP and NF-1 are likely paracrinopathies due to lifelong growth factor dysregulation.
- JNP exhibits more dynamic changes than NF-1.
- Paracrinology holds potential for treating disorders involving growth mechanism dysregulation.